When.com Web Search

  1. Ads

    related to: high dose ics inhalers

Search results

  1. Results From The WOW.Com Content Network
  2. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

    en.wikipedia.org/wiki/Fluticasone_furoate/...

    [6] [7] The medications work in different ways: fluticasone furoate is an inhaled corticosteroid (ICS), umeclidinium is a long-acting muscarinic antagonist (LAMA), and vilanterol is a long-acting beta-agonist (LABA). In 2022, it was the 144th most commonly prescribed medication in the United States, with more than 3 million prescriptions. [8] [9]

  3. Anti-asthmatic agent - Wikipedia

    en.wikipedia.org/wiki/Anti-asthmatic_agent

    Low-dose inhaled corticosteroids and formoterol maintenance therapy; Step 4: Daily symptoms, or waking with asthma once a week or more, and low lung function . Medium dose inhaled corticosteroids and formoterol maintenance therapy; Short-course oral corticosteroids when required in severely uncontrolled asthma

  4. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    When combined with inhaled steroids, β adrenoceptor agonists can improve symptoms. [1] [2] In children this benefit is uncertain and they may be potentially harmful. [2]They should not be used without an accompanying steroid due to an increased risk of severe symptoms, including exacerbation in both children and adults. [3]

  5. Budesonide/formoterol - Wikipedia

    en.wikipedia.org/wiki/Budesonide/formoterol

    Budesonide/formoterol, sold under the brand name Symbicort among others, is a fixed-dose combination medication used in the management of asthma or chronic obstructive pulmonary disease (COPD). [2] It contains budesonide, a steroid; and formoterol, a long-acting β 2-agonist (LABA). [2]

  6. Tiotropium bromide - Wikipedia

    en.wikipedia.org/wiki/Tiotropium_bromide

    Tiotropium is used as maintenance treatment of chronic obstructive pulmonary disease (COPD). [16] [17] It may also be used as an add-on therapy in people with moderate-to-severe asthma on medium to high dose inhaled corticosteroids (ICS).

  7. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    Following years of public outcry about the high cost of inhalers, the two drugmakers — along with a third, GlaxoSmithKline — have committed to capping the out-of-pocket cost at $35 a month.